Details of the Drug Reposition

General Information of This Drug (ID: DMPH1RK)

• Drug Name: Alferminogene tadenovec (DMPH1RK)
• Synonyms: Generx (TN)

Information on Drug Reposition of This Drug

2 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Angina pectoris	DISCLMC4	BA40	Phase 3	[1]
Heart disease	DISKW5KW	BA41-BA42	Phase 3	[2]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Alferminogene tadenovec, an angiogenic FGF4 gene therapy for coronary artery disease. IDrugs. 2008 Apr;11(4):283-93.